Join
Live feed
·
INSIDERFilingvia Quantisnow
Ernexa Therapeutics Inc. logo

Sr. VP of Finance Gurrola Sandra M converted options into 30 shares, increasing direct ownership by 38% to 110 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ERNA (Ernexa Therapeutics Inc.) and more on Quantisnow.